GlassScriptPhysician profile
Edward L Erb
NPI 1053313163
$3,411.09
in general payments reported to CMS, 2019-2025
35 companies · $894 in 2025
The $894 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $70.81 · 2021: $194 · 2022: $406 · 2023: $712 · 2024: $549 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,155.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $594.23 | 2021-2025 | Endurant Iis, Heli-Fx Endoanchor System, Hawkone |
| Terumo Medical Corporation | $496.34 | 2019 | |
| Janssen Pharmaceuticals, INC | $391.73 | 2019-2024 | Xarelto |
| Stryker Corporation | $382.49 | 2025 | Artix Mt, Clottriever Bold Catheter |
| Abiomed | $184.23 | 2024-2025 | Impella |
| W. L. Gore & Associates, INC. | $164.25 | 2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Scpharmaceuticals INC. | $88.30 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $83.63 | 2022-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $75.91 | 2021-2023 | |
| Bolton Medical INC | $71.19 | 2019-2024 | Treo Abdominal Stent-Graft System |
| Pfizer INC. | $70.41 | 2021-2022 | |
| Surmodics, INC. | $69.03 | 2022 | |
| Cvrx, INC. | $67.18 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $63.13 | 2023 | Inpefa |
| Merck Sharp & Dohme LLC | $59.61 | 2022-2024 | Winrevair |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $58.04 | 2024 | Artegraft Vascular Graft |
| Atricure, INC. | $56.11 | 2024-2025 | Atriclip Laa Exclusion System |
| Solventum Corporation | $48.91 | 2024-2025 | Promogran Prisma, Activ.A.C., V.A.C. Granufoam |
| Smith+Nephew, INC. | $44.69 | 2021-2023 | Renasys Go V2 Home |
| Baxter Healthcare | $39.68 | 2023 | Hillrom - Cardiac Ambulatory Monitor, Tisseel |
| Tactile Systems Technology INC | $39.41 | 2021 | |
| United Therapeutics Corporation | $32.23 | 2022-2023 | Tyvaso |
| Boston Scientific Corporation | $29.89 | 2019-2022 | |
| Cardiva Medical, INC. | $22.41 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $22.35 | 2024 | Arcalyst |
| Alexion Pharmaceuticals, INC. | $21.78 | 2021 | |
| Portola Pharmaceuticals, LLC | $19.92 | 2019 | |
| Bard Peripheral Vascular, INC. | $18.63 | 2025 | Rotarexs 6 F X 135 Cm |
| Shockwave Medical, INC | $17.72 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cook Medical LLC | $16.34 | 2025 | Rosen |
| Esperion Therapeutics, INC. | $15.50 | 2025 | Nexletol |
| Itamar Medical INC | $14.73 | 2023 | Watchpatone |
| E.R. Squibb & Sons, L.L.C. | $14.42 | 2022 | |
| Bardy Diagnostics, INC. | $12.59 | 2022 | |
| Cardiovascular Systems INC. | $4.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Erb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.